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Silk fibroin/hyaluronan scaffolds for human mesenchymal stem
cell culture in tissue engineering
Abstract
The design of new bioactive scaffolds mimicking the physiologic environment present during tissue
formation is an important frontier in biomaterials research. Herein, we evaluated scaffolds prepared
from blends of two biopolymers: silk fibroin and hyaluronan. Our rationale was that such blends would
allow the combination of silk fibroin's superior mechanical properties with the biological characteristics
of hyaluronan. We prepared scaffolds with porous microstructures by freeze-drying aqueous solutions of
silk fibroin and hyaluronan and subsequent incubation in methanol to induce water insolubility of silk
fibroin. Hyaluronan acted as an efficient porogenic excipient for the silk fibroin scaffolding process,
allowing the formation of microporous structures within the scaffolds under mild processing conditions.
Mesenchymal stem cells were seeded on silk fibroin/hyaluronan scaffolds and cultured for three weeks.
Histology of the constructs after cell culture showed enhanced cellular ingrowth into silk
fibroin/hyaluronan scaffolds as compared to plain silk fibroin scaffolds. In the presence of
tissue-inductive stimuli, in vitro stem cell culture on silk fibroin/hyaluronan scaffolds resulted in more
efficient tissue formation when measured by glycosaminoglycan and type-I and type-III collagen gene
expression, as compared to plain silk fibroin scaffolds. In conclusion, our data encourages further
exploration of silk fibroin/hyaluronan scaffolds as biomimetic platform for mesenchymal stem cells in
tissue engineering.
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Abstract 
The design of new bioactive scaffolds mimicking the physiologic environment 
for tissue formation is an important frontier in biomaterials research. Herein, 
we evaluated scaffolds prepared from blends of two biopolymers: silk fibroin 
and hyaluronan. Our rationale was that such blends would allow the 
combination of silk fibroinʼs superior mechanical properties with the biological 
characteristics of hyaluronan. We prepared scaffolds with porous 
microstructures by freeze-drying aqueous solutions of silk fibroin and 
hyaluronan and subsequent incubation in methanol to induce water insolubility 
of silk fibroin. Hyaluronan acted as an efficient porogenic excipient for the silk 
fibroin scaffolding process, allowing the formation of microporous structures 
within the scaffolds under mild processing conditions. Mesenchymal stem 
cells were seeded on silk fibroin/hyaluronan scaffolds and cultured for three 
weeks. Histology of the constructs after cell culture showed enhanced cellular 
ingrowth into silk fibroin/hyaluronan scaffolds as compared to plain silk fibroin 
scaffolds. In presence of soft chondrogenic stimuli, in vitro stem cell 
differentiation on silk fibroin/hyaluronan scaffolds resulted in more efficient 
tissue formation when measured by glycosaminoglycan and type-I and type-III 
collagen gene expression, as compared to plain silk fibroin scaffolds. In 
conclusion, our data encourages further exploration of silk fibroin/hyaluronan 
scaffolds as biomimetic platform for mesenchymal stem cells in tissue 
engineering. 
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Introduction 
An important objective in current tissue engineering research is the design of 
scaffolds that induce regenerative processes by interacting with relevant cell 
populations [1]. To achieve this goal, a scaffold should act as a biomimetic 
platform allowing cells to properly accommodate and rebuild the target tissue. 
Scaffolds should feature physical [2] and chemical cues that stimulate cell 
commitment, differentiation and regeneration of target tissues [3, 4].  
Silk fibroin (SF) and hyaluronan (HA) are two prominent biopolymers currently 
under study for the fabrication of tissue scaffolds. SF is a structural protein 
that can be extracted from silkworm silk [5]. When appropriately purified, SF is 
non-toxic, non-immunogenic and has been demonstrated to support cell and 
tissue growth [6, 7]. Additionally, SF features outstanding mechanical 
properties that resemble those of several structural tissues in the body [6], 
and has been successfully explored for the tissue engineering of bone, 
cartilage and ligaments [8-11]. In summary, SF is a well-established 
biomaterial for tissue scaffolding mainly owing to its amenability to form tissue 
conductive microstructures. On the other hand, no evidence has been found 
that B. mori SF can interact with cell receptors, or actively trigger regenerative 
processes by itself. 
HA is one of the most ubiquitous glycosaminoglycans in our body. Under 
physiological conditions, HA interacts with other biomacromolecules such as 
collagen to promote extracellular matrix assembly [12, 13]. HA can also 
interact with cells through receptors on the plasmatic membrane such as 
CD44. In turn, this receptor activates several biological effects, such as 
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modulation of angiogenic processes [14-17], induction of proinflammatory 
metalloprotease expression [18], enhancement of cell motility and invasion 
[19], and amplification of cell proliferation [20]. Other studies also indicated a 
key role of the interaction between HA and CD44 at several stages of 
embryogenesis [21], as well as for the development of adult tissues such as 
the growth plate or mature bone [22-24]. 
For tissue engineering applications, HA and HA-based scaffolds have been 
investigated for the repair of ligament [25], cartilage [26-30], adipose tissue 
[31], bone [32] and osteochondral defects [33, 34]. There were even some 
clinical tests on the efficacy of HA scaffolds for the tissue engineering of 
cartilage [27, 35], and for artery regeneration [36]. In spite of these interesting 
features, HA scaffolds present some limitations typically related to their 
inadequate mechanical properties that are further compromised by its rapid 
degradation by physiological enzymes in vivo. 
In this manuscript we present a new scaffold material based on binary blends 
of the two biomacromolecules, SF and HA. The hypothesis of our approach is 
that SF acts as the main structural and tissue conductive component of the 
scaffold, providing mechanically stable structures that undergo slow 
biodegradation over extended periods of time, while HA provides a biomimetic 
surface for mesenchymal stem cell culture and ingrowth. Additionally, we 
show that such blends can be processed to form porous microstructures that 
support 3D tissue formation, and that this pore formation is induced by a mild 
water-based freeze-drying technique that circumvents the use of harsh 
processing conditions. 
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Materials and Methods 
 Materials 
Silk cocoons from Bombyx mori were provided by Trudel Inc. (Zurich, 
Switzerland). Hyaluronan (HA) was purchased from Pronova Biopolymer, 
FMC (Drammen, Norway). Human bone marrow samples were purchased 
from Cambrex BioScience (Walkersville, MD). All other reagents were of 
analytical or higher grade. Ultrapure water (NANOpure Diamond™, Barnstead 
International, Dubuque, IA) was used throughout this study. 
Methods 
Silk fibroin purification and concentration 
Silk fibroin (SF) was isolated from silkworm cocoons and purified from its 
sericin content as previously described [5]. Briefly, cocoons were cut, cleaned 
from debris and larvae and boiled twice for an hour in Na2CO3 (2.12 mg/mL) 
solutions. Silk was then thoroughly washed with ultrapure water and dried 
overnight in a fume hood. The dry residue was dissolved at 10% 
concentration (w/v) in a 9 M LiBr solution at 55 ºC until a clear solution was 
obtained. This solution was then passed through a 5 μm syringe filter 
(Minisart® single use syringe filter, Sartorius AG, Goettingen, Germany) and 
dialyzed (Slide-A-Lyzer®, Pierce Biotechnology, Thermo Fisher Scientific, 
Waltham, MA) against an excess of ultrapure water for 48 h with a total of 5 
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changes of the water phase. For short periods of time (up to 7 days) aqueous 
silk solutions could be stably stored at 4 ºC. 
Preparation of blended SF/HA scaffolds 
HA was weighed according to the amounts required for SF to HA ratios (w/w) 
of 100:0, 88.2:11.8, 79:21 and 60:40 and dissolved in the previously purified 
SF solution (1.5% w/v). The blends were incubated under slight agitation with 
a magnetic stirrer for 1 h at room temperature for complete HA dissolution and 
to allow possible interactions between the two components. The mix was then 
allocated to Teflon containers (3 mL per container), and shock-frozen by 
immersion in liquid nitrogen for 1 minute. SF:HA matrices were obtained by 
freeze-drying. Freeze-dried matrices were finally immersed in 90% (v/v) 
methanol in water (subsequently denoted as methanol) for 45 minutes and 
dried overnight in a fume hood. The resulting blended scaffolds were stored 
for subsequent tests. Scaffolds for tissue culture were shaped into disks of 8 
mm of diameter and 2 mm of thickness using a tissue-puncher. Disk scaffolds 
were steam sterilized by autoclaving at 121ºC. Throughout this work, the 
various scaffolds will be denoted by their approximate SF:HA composition 
ratio: i.e. 100:0 (plain SF without HA, used as control), 90:10, 80:20 and 
60:40. 
Chemical composition of SF/HA matrices 
We determined the composition of the different scaffolds by elemental 
analysis as previously described [37]. The composition of the blended 
scaffolds was analyzed for their contents in C, H and N upon sample 
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combustion. Taking into account the composition of the pure materials in C 
and N, the following equations were derived for calculating the composition of 
the samples: 
[SF] = 0.07378[N] - 0.00604[C] 
[HA] = 0.0354[C] - 0.0936[N] 
where [C] is the carbon and [N] the nitrogen content of the samples, and [SF] 
and [HA] are the calculated SF and HA contents. The equations were found to 
predict the composition of standard mixtures of the polymers at an error of 
less than 1%. 
Mass loss and swelling tests 
Swelling studies were made by immersing the different scaffolds (approx. 20 
mg) in phosphate buffered saline (PBS) at 37ºC. The wet weight of the 
samples was measured (AG245, Mettler Toledo GmbH, Greifensee, 
Switzerland) and related to the initial dry weight of each sample. Results were 
expressed as swelling ratio, i.e. mass of swollen sample divided by its dry 
mass. 
Mass loss was tested by immersing different scaffolds (approx. 20 mg) in PBS 
at 37ºC for 4 days at room temperature. After incubation, samples were dried 
and the remaining mass measured (AG245, Mettler Toledo GmbH, 
Greifensee, Switzerland). Mass loss was expressed as percentage of the 
original mass of each sample. 
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Microscopy 
Scaffolds of the various SF/HA blends were cut out and inspected before and 
after methanol treatment under a stereomicroscope (Leica MS5 
stereomicroscope connected to a Leica DFC290 camera, Leica Microsystems 
AG, Switzerland). 
Methanol treated samples were also observed by scanning electron 
microscopy (SEM). SEM samples were coated with platinum prior to 
evaluation with a LEO 1530 GEMINI scanning electron microscope (Zeiss, 
Cambridge, UK). 
Histological sections (see below) were inspected by light microscopy (Axiovert 
35 microscope, connected to an AxioCam MRc5 camera, Carl Zeiss AG, 
Germany). 
Cell culture 
Human derived mesenchymal stem cells (MSCs) were isolated from total 
bone marrow by density gradient centrifugation (two different donors, 25 cm3 
harvests). Briefly, bone marrow suspension was diluted with RPMI/FBS 
medium and mixed gently. The diluted bone marrow was centrifuged (300 x g, 
10 min, 4 ºC), the supernatant removed, and the cells resuspended in 
expansion medium (Dulbeccoʼs Minimum Essential Medium (DMEM), 10% 
Foetal Bovine Serum, nonessential amino acids, 1 ng/mL fibroblast growth 
factor). Resuspended cells were seeded at a density of 5,000 cells/cm2 in 500 
cm2 flasks and cultured in expansion medium. MSCs were allowed to reach 
80% confluence before being subcultured by trypsinization and replating. 
Second passage cells were used throughout this work. 
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The expression pattern of six surface markers was characterized to identify 
the resulting cell population [8, 10, 38]. The following markers were analyzed 
using fluorescence-activated cell sorting: CD14 (lipopolysaccharide receptor), 
CD31 (platelet endothelial cell adhesion molecule-1/endothelial cells), CD34 
(sialomucin/hematopoietic progenitors), CD44 (hyaluronate receptor), CD71 
(transferrin receptor/proliferating cells), and CD105 (endoglin). MSCs were 
also checked for their potential of osteogenic and chondrogenic differentiation 
as previously described [38]. 
Tissue culture 
For tissue culture MSCs were suspended at a concentration of 106 cells per 
mL, and this suspension seeded onto prewetted scaffolds placed in 6-well 
non-tissue culture treated plates (Becton-Dickinson AG, Switzerland). Using 
this setup, cells were cultured for 2 h at 37ºC to allow cell attachment to the 
scaffolds. During this incubation step, 10 μl of DMEM were added to the 
scaffolds every 15 min to keep them wet. Afterwards, MSCs were cultured in 
DMEM with 10% fetal bovine serum, 0.1 mM non-essential amino acids, 50 
µg/mL ascorbic acid-2-phosphate, penicillin G-streptomycin-amphotericin B, 
10 nM dexamethasone and 1 ng/mL transforming growth factor-β1 (TGF-β1) 
for 21 days. The resulting tissues were evaluated biochemically, histologically, 
and for the expression of two marker genes (Collagen type-I and type-III). 
Biochemical evaluation 
For DNA analysis, three tissue samples per group were disintegrated by using 
steel balls and a MiniBead beater (Biospec, Bartlesville, OK). DNA content 
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was measured fluorometrically by using the PicoGreen assay (Molecular 
Probes, Basel, Switzerland) according to the manufacturerʼs protocol. To 
quantify glycosaminoglycan (GAG) content, four tissue samples per group 
were digested for 16 h with 1 mL of 2.4 U/mL papain solution in buffer (0.1 M 
disodium hydrogen phosphate, 0.01 M EDTA disodium salt, 14.4 mM L-
cysteine) at 60 ºC. GAG content was determined spectrophotometrically (Cary 
50, Varian, Zug, Switzerland) at 525 nm following binding to 
dimethylmethylene blue dye, and using chondroitin sulfate as standard. 
 Histological evaluation 
For histology, tissue samples were fixed in neutral-buffered formalin (24 h at 4 
ºC), dehydrated in graded ethanol solutions, bisected through the centre, 
embedded in paraffin, cut into 5 μm thick sections and mounted on 
SuperFrost microscope slides (Microm International AG, Volketswil, 
Switzerland). Samples were stained with hematoxylin and eosin, dehydrated 
through xylene, mounted and placed under a coverslip.  
RNA isolation and real time RT-PCR 
For the quantification of gene expression, six tissue samples per group were 
transferred to 2 mL plastic tubes containing 1 mL Trizol (Invitrogen AG, Basel, 
Switzerland) and two steel balls. Tissue constructs were mechanically 
disintegrated by action of the steel balls in a Minibead beater (Biospec. 
Products, USA), and RNA was extracted from the cells by incubation in 
chloroform. The samples were centrifuged at 12,000 x g for 15 min and the 
supernatant was collected and mixed (1:1; v/v) with 70% ethanol. The 
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samples were put on a RNeasy minispin column (Qiagen, Hombrechtikon, 
Switzerland) and RNA was isolated and eluted according to the 
manufacturerʼs protocol. 
The RNA samples were reverse-transcribed to complementary DNA by using 
oligo (dT)-selection using a SuperScript First-Strand Synthesis System for RT-
PCR (Invitrogen AG, Basel, Switzerland) according to the manufacturerʼs 
instructions. Collagen types I and III were quantified using an ABI Prism 7000 
Real Time PCR system (Applied Biosystems, Rotkreuz, Switzerland) under 
standard conditions [9]. The data were normalized to the expression of the 
housekeeping gene glyceraldehyde-3-phosphate- dehydrogenase (GAPDH). 
Primers and probes for human collagen type-I and type-III (Assay on 
Demand, Hs00164004_m1 and Hs00164103_m1, respectively) and for the 
GAPDH endogenous control (reference 4333764F) were purchased from 
Applied Biosystems (CA, US). 
Statistical analysis 
All statistical analyses were performed with SPSS 13.0 statistical package 
(SPSS Inc., Chicago, IL, US). Means were compared by one-way ANOVA, 
and Tuckey HSD tests were used for post-hoc contrast. Values of p<0.05 
were considered significant. 
 
Results and Discussion 
Previously, we characterized blends composed of silk fibroin (SF) and 
hyaluronan (HA) by focusing on the molecular interactions between both 
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components [37]. Here, we aim at evaluating this biomaterial for the design of 
scaffolds for potential application in tissue engineering. Our hypothesis was 
that SF and HA could be blended in the form of porous polymeric structures 
that combine the main advantages of these biomaterials and circumvent their 
main limitations. Accordingly, in this work we designed new microporous 
SF:HA scaffolds for tissue engineering purposes. The scaffolds were 
characterized with respect to their composition and structure, and they were 
finally tested in vitro to assess their potential as platform for tissue 
engineering. 
 
Scaffold design: composition and microstructure 
Our initial strategy to design SF:HA scaffolds was by freeze-drying aqueous 
solutions of both compounds. This approach was based on the work of 
Cascone et al. who showed that porous matrices (pore size 10-50 μm) may 
be prepared just by freeze-drying a structural polymer (polyvinylalcohol) with a 
blender (HA or gelatine) [39]. An interesting feature of this method is that it 
avoids the use of conventional porogens and the associated harsh 
manufacturing protocols that are typically required to extract them, such as 
leaching with aqueous or organic media [8, 40]. Therefore, this method may 
have an advantage over existing protocols, particularly when the co-
processing of sensitive biologics (e.g. cytokines, growth factors) into SF-
based scaffolds as implant material is envisaged, e.g., for the purpose of 
controlled stem cell differentiation through controlled growth factor delivery.  
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In order to make SF insoluble in aqueous media, the scaffolds were subject to 
an additional methanol treatment for 45 min, which is well known to result in a 
transition of SF into a silk II conformation [6]. In its silk II conformation SF is 
water insoluble as well as more mechanically resilient and contracted [37].  
To characterize the prepared scaffolds, we first analyzed their composition by 
elemental analysis. The objective was to discard the possibility that fractions 
of the starting materials were lost during scaffold preparation, particularly 
during their incubation in methanol. Elemental analysis showed that the 
composition of the scaffolds was close to their theoretical values as reported 
before [37]. Therefore, only minimal quantities of the starting materials were 
assumed to be lost. 
We further studied the microstructures of the scaffolds by stereomicroscopy 
(Fig. 1) and scanning electron microscopy (Fig. 2). This allowed a first 
approximation to evaluate whether the scaffoldsʼ architecture was adequate 
for tissue engineering purposes. Prior to incubation in methanol, all scaffolds 
exhibited a homogeneous, cotton-like structure (Fig. 1, A-D). At this 
magnification their microstructure appeared to be non-porous, and thus 
inadequate for tissue engineering purposes. 
Methanol treatment was found to transform the blended scaffolds into a 
porous microstructure (Fig. 1, F-H), whereas plain SF scaffolds (SF:HA 100:0, 
Fig. 1E) remained as before. In blended scaffolds, pores were 
homogeneously distributed, and their occurrence increased in scaffolds with 
the highest HA content (Fig. 1, E-H). Thus, HA acts as a porogenic excipient 
during scaffold preparation and methanol treatment, though its mechanism is 
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as yet unclear. Our current hypothesis relies on two observations from our 
previous work [37]: (i) upon exposure to methanol, HA leads to enhanced 
crystallization (and therefore contraction) of SF; and (ii) upon treatment with 
methanol, SF:HA matrices form phase-separated HA-rich domains that 
collapse in the form of dense films. The collapsed HA-rich domains could be 
the cause of void spaces in the matrix, which then are further enlarged as the 
contracting SF walls pull apart from each other. A similar role for HA has been 
proposed by Fedarko et al. for the growing bone matrix [23, 24]. These 
authors suggested that HA captures space in immature bone for subsequent 
matrix deposition. In analogy to this biological function of HA, scanning 
electron microscopy of our scaffolds confirmed both the porous microstructure 
of SF:HA scaffolds (Fig. 2, B-D) and the non-porous microstructure of the 
plain SF scaffold (Fig. 2A). Pore sizes were in the range of 100-400 μm, an 
optimal size for tissue engineering applications [41]. This outcome contrasts 
with the non-porous structure of plain SF scaffolds and with the small pores 
observed in polyvinylalcohol/HA scaffolds as prepared by Cascone et al. [39]. 
Imaging by scanning electron microscopy also showed that SF:HA scaffolds 
have smoother internal surfaces than plain SF scaffolds (Fig. 2, E-H). 
However, on the small micrometer scale all samples exhibited significant 
micro-roughness. Importantly, micro-roughness has been related to improved 
cell attachment and better tissue-biomaterial interaction [42]. 
Freeze-drying represents an alternative to the classical hexafluoro-2-propanol 
based protocol used for SF scaffold preparation [5, 6], as well as to some 
water-based techniques that have been recently reported [40, 43]. In addition, 
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there are some advantages over the previous methodologies. Firstly, no 
conventional porogens were needed to form the scaffold circumventing the 
necessity to leach out these porogens form the scaffold in a second process 
step. Accordingly, the protocol minimizes the use of organic solvents and 
avoids harsh preparation conditions (e.g. high ionic strength, high 
temperature). Future work should better detail the interconnectivity of the 
microstructure created with this method; nevertheless, as outlined below, cell 
experiments suggest some degree of pore interconnectivity. 
 
To further elucidate the performance of SF:HA scaffolds in biological medium 
we also incubated our systems in PBS at 37ºC for several hours. It has been 
previously reported that HA can increase the penetration of cells into scaffolds 
due to increased swelling in biological media [16]. For that reason, we tested 
the swelling behavior of our scaffolds (Fig. 3A). Additionally, for their 
successful use in tissue engineering, scaffolds need to maintain their integrity 
for prolonged periods of time. Therefore, we also tested the mass loss of the 
scaffolds in PBS at 37ºC over time (Fig. 3B). 
We observed that the swelling equilibrium of all the scaffolds was achieved 
within the first hour (Fig. 3A). Within 30 min, increased swelling was observed 
for SF:HA (60:40) as compared to other scaffolds (p<0.05). After one hour, 
SF:HA (80:20) also showed increased swelling (p<0.05) as compared to 
SF:HA (90:10) and SF:HA (100:0). For SF:HA (80:20) and SF:HA (60:40) 
differences to the other samples consolidated as the experiment progressed 
(p<0.01). As a limitation of this study, we noted that with the current 
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experimental settings no distinction polymer swelling and capillary water 
uptake into the porous microstructure could be made. In any case, we assume 
that an enhanced capacity to take up water may contribute to the ability of 
SF:HA scaffolds to accommodate cells and tissue growth. 
The mass loss test (Fig. 3B) showed that SF:HA scaffolds maintained their 
integrity over 96 h of incubation in PBS at 37ºC. The only exception was 
SF:HA (60:40) that underwent near 40% of mass loss over the duration of the 
experiment. To gain better insight into this process, we analyzed the 
composition of this formulation after the mass loss test using elemental 
analysis (Fig. 4). The results indicated that only small amounts of HA 
remained in the composition after the mass loss test. HA is soluble in PBS, 
and therefore, appears to be leached out while being incubated in this 
medium. In this sense, it is interesting to note the kinetics of the mass loss 
from SF:HA (60:40) scaffolds, lasting 50 h, and being almost linear during the 
first 20 h. Obviously, the scaffolds behave as a controlled release system of 
HA. This feature will possibly allow the interaction of HA in soluble form with 
cells seeded onto the scaffolds. 
Application of SF:HA scaffolds to tissue engineering 
Cells respond to several microenvironmental cues, such as the mechanical 
properties and the nano-/microstructure of the matrix that the cells colonize [1, 
2, 41]. They also respond to specific chemical moieties on the surface of the 
supporting matrix [3, 5]. All this results in several possibilities to modulate 
regenerative responses through rational scaffold design. 
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Taking plain SF scaffolds as reference, HA modified scaffolds feature several 
characteristics that may affect their cross-talk with cells: (i) different 
mechanical properties (as reported before [37]), (ii) different microstructure, 
and (iii) presence of functional groups (from HA) capable of interacting with 
cells and other macromolecules of the extracellular matrix. To evaluate the 
scaffolds for their potential as platform for tissue engineering, we cultured 
mesenchymal stem cells (MSCs) for 3 weeks on SF:HA scaffolds in 
chondrogenic medium containing dexamethasone and transforming growth 
factor-β1 (TGF-β1). Previous experiments in our laboratory suggested that 
this medium resulted in only moderate changes in gene expression, cell 
proliferation and extracellular matrix deposition in MSC cultures (M. Garcia-
Fuentes, unpublished data). Therefore, we expected this system as being 
particularly discriminative to evaluate potential biological effects of SF:HA 
scaffolds. 
After cell culture of the MSCs on the scaffolds for 3 weeks, we analyzed the 
resulting outcomes, first focusing on tissue distribution. Basically, we checked 
whether the improved microstructure and larger swelling ratio of the SF:HA 
scaffolds were translated into a more homogenous distribution of the cells in 
the scaffolds.  
Histological sections confirmed a more homogenous distribution of the cells in 
SF:HA (60:40) scaffolds (Fig. 5D) as compared to SF:HA (100:0) (Fig. 5A). 
We observed a band-like cell accumulation on the surface of both types of 
scaffolds (Fig. 5A and 5D; Fig. 5B and 5E). Cells appeared to be elongated 
with fibroblast-like morphologies (Fig. 5B and 5E), and some cells on the 
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surface of SF:HA (100:0) showed highly eosinophilic cytoplasm and 
karyopycnotic nuclei suggesting necrosis (Fig. 5B). Differences among 
scaffolds with and without HA were observed primarily in the core. The core 
region of SF:HA (100:0) scaffolds was free of cells. In contrast, MSCs were 
found to readily colonize the core region of SF:HA (60:40) scaffolds (Fig. 5F). 
Therefore, our results imply improved tissue distribution that may be linked to 
a more favorable pore-structure and improved hydrophilicity of the material, 
which may have facitiltated cell adhesion and growth, e.g., as a result of 
enhanced nutrient transport. 
In addition to the effects by microstructure, the effect of HA on cell penetration 
and ingrowth into the scaffolds may be mediated by other mechanisms as 
well. In fact, several reports showed that scaffolds modified with HA may 
enhance cell penetration [16, 29, 34], through mechanisms unrelated to 
scaffold microstructure. The work of Holifield et al. [19] has cast some light on 
this issue by showing that CD44 (i.e. the main cell receptor for HA) plays an 
important role in cell motility and cell invasion. Importantly, CD 44 has been 
identified on several of the major cellular types responsible for structural 
tissue homeostasis, such as osteoclasts, chondroclasts, osteocytes, 
hematopoietic marrow cells, synovial cells, and connective tissue fibroblasts 
[44]. 
While the effect of HA on the cellular penetration of the scaffold was distinct, 
no other changes on cell behavior were evident from the histological sections. 
MSCs on both plain SF and SF:HA scaffolds showed the typical spindle shape 
characteristics pointing towards their non-differentiated state. This is a first 
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indication that by themselves, such scaffolds cannot trigger the differentiation  
of MSCs.  
Despite the limited effects of scaffold composition on cell response suggested 
by the histological sections, the biological activity of SF:HA scaffolds was 
further studied on the basis of selected biochemical markers. Fig. 6 shows 
DNA and GAG contents of MSCs cultured for 3 weeks on SF:HA (60:40) and 
SF:HA (100:0) scaffold. In the first place, no changes in total DNA per sample 
were detected between tissue constructs grown on SF:HA (60:40) scaffolds 
versus constructs grown on SF:HA (100:0) scaffolds. This seems to be 
contradictory to the fact that increased cell penetration was observed in 
scaffolds containing HA. The result also contrasted to previous observations 
suggesting a mitogenic effect of HA in scaffolds [29, 30, 45]. In our case, we 
suggest that the observed result may be based on the accumulation of cells 
on the surface of the control SF:HA (100:0) scaffolds that could compensate 
for the reduced population in the core. Moreover, it has been previously 
proposed that the molecular weight of HA has a marked effect on its mitogenic 
properties, making it unlikely that high molecular weight HA, as used in this 
study, affects cell proliferation [46]. 
Upon quantification of GAGs we observed higher contents on SF:HA (60:40) 
scaffolds versus SF:HA (100:0) scaffolds. Indeed, GAG content of SF:HA 
(60:40) was significantly (p<0.05) above that of SF:HA (100:0) (Fig. 6). The 
fact that HA is a GAG itself makes it more difficult to interpret this result. 
Therefore, to evaluate the potential interference of HA in the scaffold with the 
outcome of the experiment, we incubated the SF:HA (60:40) scaffolds without 
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cells for 3 weeks in the same medium and then measured their GAG content. 
The results showed consistent values below 0.8 μg GAG per mg of the 
construct (results not shown). This value is far too small to explain the 
increase in GAG levels as observed for the blended scaffolds. However, 
release of HA from the scaffold cannot be excluded, and thus its interaction 
with components of the extracellular matrix and its incorporation therein [13]. 
The capacity of HA to enhance GAG deposition in tissue engineered 
constructs is in agreement with other work related to HA-based scaffolds [29, 
45] and underlines the current interest in HA-based biomaterials for tissue 
engineering applications [12, 18, 47]. 
Finally, we aimed at studying the capacity of such scaffolds to affect the 
expression of selected genes. There are several reports available on the 
capacity of HA to change cell programming and gene expression. However, 
information is still incomplete, and seems to be largely dependent on structure 
and overall composition of the scaffold. This is best illustrated by the reported 
effect of different HA-containing scaffolds on the expression of collagen type-
II. While several reports indicate that HA induces expression of this structural 
protein [27, 48, 49], others observed downregulation when cells were cultured 
on HA scaffolds [25]. The general tendency is that scaffolds based on HA 
favor proliferation [50], inhibit the production of proteins that mediate cell 
attachment [25], up-regulate the expression of cartilage related genes [27, 30, 
48, 49, 51], and modulate the expression of inflammatory and catabolic 
markers [49, 51, 52]. The relation between HA composition, bone related 
genes and extracellular matrix components (e.g. collagen type-I and type-III) 
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seems to be specific for each particular scaffold [25, 27, 50, 53]. Although the 
(often contradictory) results have been typically linked to a direct effect of HA, 
it is still questionable whether some of them might be causally related to the 
unsatisfactory mechanical properties of HA-based scaffolds.  
The results of the relative expression levels of collagen type-I and collagen 
type-III for SF:HA (100:0) and SF:HA (60:40) are presented in Fig. 7. Real 
time RT-PCR confirmed that SF:HA (60:40) significantly up-regulated (p<0.05) 
the expression of both collagens. This is remarkable since collagens of type-I 
and type-III are present in most tissues of the body. Additionally, the result 
confirmed our hypthesis that SF:HA scaffolds provide some degree of 
inherent biological activity. The underlying molecular mechanism is still not 
completely understood. However, it is known that HA interacts with cells 
through CD44. This interaction has been coupled to c-myc and TGF-β mRNA 
expression [20], which in turn may contribute to the observed biological 
effects (e.g. enhanced GAG deposition, enhanced collagen expression, etc.). 
Upregulation of the TGF-β pathway can have several potential applications 
such as, among others, for the design of biomimetic scaffolds for cartilage and 
ligament replacement. However, the hypothesis that the TGF-β pathway is a 
significant driver for the observations described herein still requires 
experimental confirmation.  
 
Conclusions 
We prepared scaffolds based on binary blends of SF and HA. This 
composition allowed the formation of microstructures that enhanced tissue 
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ingrowth. Because the straightforward formation of such microstructures 
depended on freeze-drying only, this protocol circumvents the need for 
conventional porogens and leaching steps with organic solvents or water. 
Therefore, this technology is highly attractive for the incorporation of biologics 
such as cytokines and growth factors into scaffolds. Studies with human 
mesenchymal stem cells indicated that a combination of silk fibroin and 
hyaluronan is capable to trigger regenerative stimuli, which could be 
particularly interesting for cartilage regeneration. In summary, SF:HA blends 
exhibit interesting properties for tissue engineering, and may offer superior 
performance over scaffolds based on plain components. 
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Figure Captions 
 
Figure 1: Stereomicroscope images (x10 magnification) of SF:HA scaffolds: 
100:0 (A, E), 90:10 (B, F), 80:20 (C, G) and 60:40 (D, H). Images A-D were 
taken before methanol treatment; images E-H were taken after methanol 
treatment. 
Figure 2: Scanning electron microscopy images of different scaffolds after 
methanol treatment: SF:HA (100:0) (A, E), SF:HA (90:10) (B, F), SF:HA 
(80:20) (C, G) and SF:HA (60:40) (D, H). Figures A-C are at 350-fold 
magnification (bar=100 μm); figures E-H are made at 2000-fold magnification 
(bar=10 μm). 
Figure 3: (A) Swelling ratios (w/w) and (B) percentage of the initial scaffold 
mass remaining after incubation over time in phosphate buffer saline at 37ºC 
(mean ±SD, n=3). Groups are: ( ) SF:HA (100:0), ( ) SF:HA (90:10), ( ) 
SF:HA (80:20) and ( ) SF:HA (60:40). Statistical significances: *p<0.05, 
**p<0.01. 
Figure 4: Composition of the scaffolds after 4 days of incubation in phosphate 
buffer saline at 37ºC as derived from combustion C,H,N-elemental analysis 
(bars represent means ±SD, n=3). For comparison purposes, we also 
represent the actual composition of the scaffolds after preparation (lines 
above the bars). Data from the composition of the scaffolds directly after 
preparation (lines above bars) is taken with permission from {Garcia-Fuentes, 
2008 #74}. 
Figure 5: Hematoxylin-eosin stained histological images of mesenchymal 
stem cells grown on SF:HA (100:0) (A-C) or SF:HA (60:40) (D-F) scaffolds for 
21 days. (A, D) General images (bar= 500 μm); (B, E) Detail of the outer layer 
of the tissue constructs; (C, F) detail of the core of the constructs 
approximately 500 μm deep (bar= 100 μm). The featured outer layer and core 
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images correspond to the regions of the general images indicated by the 
arrows (“I” and “II” respectively). 
Figure 6: DNA (left axis, empty bars) and GAG (right axis, filled bars) content 
of tissues cultured for 21 days in SF:HA (100:0) or SF:HA (60:40) scaffolds 
(mean ±SD, n=4). *Statistically significant at p<0.05. 
Figure 7: Gene expression levels of collagen type-I and type-III in tissues 
cultured for 21 days in SF:HA (100:0) (☐) or SF:HA (60:40) (■) scaffolds 
(mean ±SD, n=6). Results were normalized to an endogenous control gene 
(GAPDH) and expressed in relation to mesenchymal stem cells before 
seeding. *Statistically significant at at p<0.05 
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